Cora Capital Advisors »

Regeneron Pharmaceuticals shares owned by Cora Capital Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Cora Capital Advisors from 13F filings

Historical chart of Cora Capital Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Cora Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Cora Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $204k 264 771.87

More positions owned by Cora Capital Advisors

Ishares Tr U S Equity Factr (LRGF)
T Rowe Price Etf Cap Appreciation (TCAF)
Vanguard Index Fds Growth Etf (VUG)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Us Sml Cap Eqt (SMLF)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Msci Emrg Chn (EMXC)
Microsoft Corporation (MSFT)
Proshares Tr S&p 500 Dv Arist (NOBL)
Ishares Tr Future Ai & Tech (ARTY)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Cora Capital Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management
Nuveen

View all funds holding Regeneron Pharmaceuticals